Biological Dynamics, Inc.
9381 Judicial Drive
20 articles with Biological Dynamics, Inc.
Biological Dynamics, Inc., a biotechnology company focused on detecting diseases at the earliest stages, announced participation in a series of global events to discuss industry trends and challenges, and to preview new early-stage cancer detection data based on the company’s novel Verita™ technology.
Biological Dynamics, Inc. announces the publication of its study, Early-Stage Multi-Cancer Detection Using an Extracellular Vesicle Protein-Based Blood Test, published in Nature Communications Medicine.
3/11/2022Biopharma and life sciences organizations strengthen their leadership teams and boards with these Movers & Shakers
Precision Medicine Expert Dr. Paul Billings Rejoins Biological Dynamics, Inc. as Chief Executive Officer and Director
Biological Dynamics, Inc., a novel multiomic test company focused on detecting diseases at their earliest stages, announced the return of Paul Billings, MD, PhD, FACP, FACMGG to the company as Chief Executive Officer and Director.
FDA Grants Breakthrough Device Designation for Biological Dynamics’ Early-stage Pancreatic Cancer Detection Test
Biological Dynamics, Inc., a multiomics liquid biopsy company focused on detecting cancers at the earliest stages, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its liquid biopsy assay, Exo-PDAC.
Biological Dynamics, Inc. will present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California. The panel discussion takes place on Tuesday, August 10, 2021 at 7:00 p.m. PT.
Biological Dynamics, Inc., a next-generation liquid biopsy company focused on detecting cancers at the earliest stages, will participate in the Nephron Research Liquid Biopsy Innovation Symposium
Company to Webcast Presentation Tuesday, January 12, 2021 at 5:30 p.m. ET
Veteran life science investor and industry analyst brings robust financial acumen and life science sector expertise to next-generation liquid biopsy company
Biological Dynamics Expands Biomarkers Research Into Alzheimer's With Funding From Alzheimer's Drug Discovery Foundation (ADDF)
Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, announces a new biomarkers program designed for drug development applications in Alzheimer's D
Supplemental funding from the Bill & Melinda Gates Foundation supports study of Biological Dynamics' novel TB detection test performance using clinical samples
Biological Dynamics Enters Collaboration to Advance Access to Novel Diagnostic Solutions to Life Science Customers
Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health, today announced it has been accepted to Microsoft's One Commercial Partner (OCP) program.
Biological Dynamics Receives Grant Award Funding to Advance Point-of-Care Molecular Diagnostic Platform
Biological Dynamics, Inc., an innovative diagnostic company committed to improving global health outcomes, today announced a new grant award from the Bill & Melinda Gates Foundation.
Biological Dynamics to Present at Biotech Showcase 2019 During Annual J.P. Morgan Conference in San Francisco
Biological Dynamics today announced the company will present at the Biotech Showcase™ 2019 conference, taking place during the annual J.P. Morgan Healthcare Conference on January 7-9 at the Hilton San Francisco Union Square.
Biological Dynamics, a company committed to improving global health outcomes by empowering global communities with accessible cancer diagnostics, today announced that its OmniVerita™ system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage category.
Biological Dynamics Awarded Grant to Develop the Next Generation of Smartphone-Enabled Tuberculosis Tests
Grant to help address the pressing need of reducing the burden of tuberculosis (TB) in resource-poor settings
Company’s OmniVerita Designed to Enable Early Detection and Monitoring of Cancer
Dr. Jacobs is founding Chairman and CEO Emeritus of Qualcomm and Chairman Emeritus of the Salk Institute for Biological Studies.
Biological Dynamics, a molecular diagnostics company dedicated to improving global health outcomes by empowering global communities with low-cost, accessible cancer diagnostics, today announced that new data on the company’s novel technology (ACE) will be presented at the American Association for Cancer Research 2018 Annual Meeting, at McCormick Place Convention Center on April 13 – 18 in Chicago.
Biological Dynamics Announces the Addition of Irwin M. Jacobs and Martin J. Wygod to its Board of Directors
Strategic Additions Bring Global Operations and Commercialization Expertise